Corporate Profile
LianBio (NASDAQ: LIAN) is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in Greater China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio’s model leverages a number of key elements, including transformative in-licensing, development and commercialization approaches designed to deliver innovative therapeutic solutions to patients. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets.
Stock Quote
Price
Change
High
Minimum 15 minutes delayed. Source:
News Releases
February 28, 2024
February 13, 2024
December 26, 2023
Events & Presentations
June 15, 2023 at 10:00 AM PDT
June 8, 2023 at 4:30 PM EDT
May 1, 2023 at 8:00 AM EDT
Contact